Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1321.62 Million | USD 1981.03 Million | 4.6% | 2023 |
The global Inhalation Anesthesia Market size was valued at USD 1321.62 Million in 2023 and is predicted to reach USD 1981.03 Million by the end of 2032. The market is expected to grow with a CAGR of 4.6% during the forecast period. The report analyzes the global Inhalation Anesthesia Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Inhalation Anesthesia industry.
The report analyzes the global inhalation anesthesia market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the inhalation anesthesia industry.
Anesthesia is a medicinal treatment that averts patients from sensing pain during surgical procedures. Anesthesia helps people to undergo surgical procedures that result in healthier lives. A wide variety of drugs known as anesthetics are used for producing anesthesia with different effects like local, regional, and general. General anesthetics make patients sleep throughout the entire procedure. Regional and local anesthetics only numb specific body parts, where patients are awake during the procedure. An inhalation anesthetic is a chemical complex holding general anesthetic features that can be transported via inhalation. Inhalation anesthetics are administered through a laryngeal mask airway, face mask, or anesthetic vaporizer with a tracheal tube.
The study includes drivers and restraints of the inhalation anesthesia market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the inhalation anesthesia market on a global and regional level.
In order to give the users of this report a comprehensive view of the inhalation anesthesia market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
Growing emergency and trauma cases, rising cancer incidences, increasing respiratory, cardiovascular, gastrointestinal, neurological, and orthopedic disorders, escalating preference for short hospital stay, increasing number of surgical procedures, various advantages of inhalation anesthesia over intravenous anesthesia, growing load of chronic disorders, access to health insurance coverage, are major driving factors of the inhalation anesthesia market. Constant improvements in the healthcare set-up, innovations in the field of inhalation anesthetics, and rising elderly population globally will act opportunities for the players in the inhalation anesthesia market. However, some side effects of inhalation anesthetics, competition from generic versions, less adoption of inhalation anesthetics in some surgical procedures, rigorous government regulations, and lack of awareness may restrict the inhalation anesthesia market globally.
The report provides a company market share analysis to give a broader overview of the key players in the inhalation anesthesia market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the inhalation anesthesia market on a global and regional basis.
Report Attributes | Report Details |
---|---|
Report Name | Inhalation Anesthesia Market |
Market Size in 2023 | USD 1321.62 Million |
Market Forecast in 2032 | USD 1981.03 Million |
Growth Rate | CAGR of 4.6% |
Number of Pages | 201 |
Key Companies Covered | AbbVie, Lunan Pharmaceutical, Baxter, Halocarbon Products, Hikima Pharmaceuticals, Piramal Enterprises, Fresenius Kabi, and Jiangsu Hengrui Medicine |
Segments Covered | By Product Type, By End-User, By Application and By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some key players in the inhalation anesthesia market are
The inhalation anesthesia market is fragmented into product, end-user, and application. Based on product, the inhalation anesthesia market includes desflurane, isoflurane, sevoflurane, and others. The isoflurane segment is expected to register the highest CAGR in the future. The end-user segment includes ambulatory surgical centers, hospitals and clinics, and others. The application segment comprises maintenance and induction.
The North American inhalation anesthesia market will be leading over the forecast time period and accounted for over 40% of the global share in 2023. This can be attributed to the rising chronic diseases, growing number of surgical procedures, the presence of modern healthcare facilities, and early acceptance of latest technologies. Europe will hold the second spot in the global market, owing to the presence of trained anesthesiologists, high research and development investment by top companies, growing geriatric population, increasing prevalence of chronic ailments, and encouraging reimbursement scenario. The Asia Pacific will grow rapidly over the forecast period, due to the rising incidence of chronic diseases, growing interest in inhalation anesthesia, increasing R&D related to anesthesia, and rising trauma emergencies.
The study provides a decisive view of the inhalation anesthesia market by segmenting the market based on product, end-user, application, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Global Inhalation Anesthesia Market: By Product
Global Inhalation Anesthesia Market: By End-User
Global Inhalation Anesthesia Market: By Application
Global Inhalation Anesthesia Market: By Region
FrequentlyAsked Questions
Inhalation anesthesia, also known as volatile anesthesia or gas anesthesia, is a medical technique used to induce a state of unconsciousness and insensitivity to pain during surgical procedures or medical interventions. This type of anesthesia involves administering specific volatile anesthetic agents to a patient through inhalation, typically by breathing the agents in through a mask or a breathing tube.
Advances in inhalation anesthesia delivery systems, monitoring devices, and anesthetic agents can drive market growth. Innovative technologies that enhance patient safety, improve precision in dosage delivery, and reduce side effects can attract both healthcare providers and patients.
The global inhalation anesthesia market size was evaluated at $1.24 Billion in 2018 and is slated to hit $1.73 Billion by the end of 2025.
a CAGR of nearly 4.9% between 2019 and 2025.
The study provides a decisive view of the inhalation anesthesia market by segmenting the market based on product, end-user, application, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Some key players in the inhalation anesthesia market are AbbVie, Lunan Pharmaceutical, Baxter, Halocarbon Products, Hikima Pharmaceuticals, Piramal Enterprises, Fresenius Kabi, and Jiangsu Hengrui Medicine.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed